A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo

Yijia Li(City Of Hope National Medical Center), Hua Yu(City Of Hope National Medical Center)
Molecular Therapy
July 31, 2024
Cited by 2


Related Papers